About JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND
Expense ratio
0.40%
Home page
Inception date
May 9, 2022
ISIN
CNE100005B86
Closely tracks the underlying index, and pursues the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.84%
Health Technology90.66%
Commercial Services8.37%
Process Industries0.50%
Health Services0.31%
Bonds, Cash & Other0.16%
Cash0.16%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history